Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fidrisertib - Ipsen

Next Previous
X
Search
Drug Profile

Fidrisertib - Ipsen

Alternative Names: BLU-782; IPN-60130

Latest Information Update: 05 Nov 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Blueprint Medicines
  • Developer Blueprint Medicines; Ipsen
  • Class Carbamates; Furans; Piperazines; Piperidines; Pyridazines; Pyridines; Pyrroles; Small molecules
  • Mechanism of Action ACVR1 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Fibrodysplasia ossificans progressiva
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Fibrodysplasia ossificans progressiva

Most Recent Events

  • 01 Dec 2021 Phase-II clinical trials in Fibrodysplasia ossificans progressiva (In adolescents, In children, In the elderly, In adults) in Germany, Netherlands, Spain, United Kingdom, USA (PO) after December 2021 (NCT05039515) (EudraCT2020-002858-24)
  • 01 Dec 2021 Phase-II clinical trials in Fibrodysplasia ossificans progressiva (In adults, In the elderly, In adolescents, In children) in Italy, Sweden (PO) (EudraCT2020-002858-24) (NCT05039515)
  • 17 Feb 2021 Phase-II clinical trials in Fibrodysplasia ossificans progressive in USA (PO), prior to February 2021 (Ipsen pipeline, February 2021)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top